Visalytics
Visalytics
dismissed EB-2 (NIW)

Medical Scientist

Biomedical Science · 2025-03-17

Decision Date
2025-03-17
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to work in the field of biomedical science to improve cancer prevention and treatment. She intends to focus on creating new predictive biomarkers, therapeutic targets, and medications for cancer precision therapies by identifying and characterizing genes, proteins, and signaling pathways.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Not Met

The record failed to show that the specific endeavor has national or global implications or significant potential for economic impact.

Why This Petition Was Denied

The appeal was dismissed because the petitioner failed to establish the national importance of her specific endeavor under the first Dhanasar prong. While she provided publications and letters of recommendation, they were deemed too generalized and did not demonstrate how her specific work would impact the field more broadly or provide substantial economic effects.

Evidence

Evidence Types
Peer Reviewed Publications
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
Georgia 146 days 2025-01-09
The petitioner proposes to continue conducting research and developing novel strategies and therapies to target various diseases, including cancer, autoimmune diseases, and infectious diseases, to enhance biotechnology for cancer therapy and vaccine development.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
57 days 2025-03-31
The petitioner proposes to continue her research in the field of medical research, specifically focusing on the development of personalized treatment strategies for cancer and other complex diseases. Her work utilizes statistical models and artificial intelligence to interpret genomic and clinical datasets to create customized therapies that maximize efficacy and minimize adverse effects.
View Case

Scientist

Biotechnology

USCIS EB-2 (NIW) rfe sustained
Massachusetts 2024-04-12
The petitioner proposes to continue research into tumorigenesis and develop new technologies for cancer therapies. This involves utilizing biological assays to facilitate cancer drug and biomarker screening, characterization, and development, specifically focusing on phosphorylation inducing chimeric small molecules (PHICS).

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-17.

Browse all cases

At a Glance

Outcome dismissed
Criteria Met 0 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist